3,4-Methylenedioxymethamphetamine (Ecstasy) Decreases Inflammation and Airway Reactivity in a Murine Model of Asthma


Autoria(s): Stankevicius, Daniel; Ferraz-de-Paula, Viviane; Ribeiro, Alison; Pinheiro, Milena Lobao; Oliveira, Ana P. Ligeiro de; Damazo, Amilcar S.; Lapachinske, Silvio F.; Moreau, Regina Lucia de Moraes; Lima, Wothan Tavares de; Palermo-Neto, Joao
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

05/11/2013

05/11/2013

2012

Resumo

Objective:3,4-Methylenedioxymethamphetamine(MDMA), or ecstasy, is a synthetic drug used recreationally, mainly by young people. It has been suggested that MDMA has a Th cell skewing effect, in which Th1 cell activity is suppressed and Th2 cell activity is increased. Experimental allergic airway inflammation in ovalbumin (OVA)-sensitized rodents is a useful model to study Th2 response; therefore, based on the Th2 skewing effect of MDMA, we studied MDMA in a model of allergic lung inflammation in OVA-sensitized mice. Methods: We evaluated cell trafficking in the bronchoalveolar lavage fluid, blood and bone marrow; cytokine production; L-selectin expression and lung histology. We also investigated the effects of MDMA on tracheal reactivity in vitro and mast cell degranulation. Results: We found that MDMA given prior to OVA challenge in OVA-sensitized mice decreased leukocyte migration into the lung, as revealed by a lower cell count in the bronchoalveolar lavage fluid and lung histologic analysis. We also showed that MDMA decreased expression of both Th2-like cytokines (IL-4, IL-5 and IL-10) and adhesion molecules (L-selectin). Moreover, we showed that the hypothalamus-pituitary-adrenal axis is partially involved in the MDMA-induced reduction in leukocyte migration into the lung. Finally, we showed that MDMA decreased tracheal reactivity to methacholine as well as mast cell degranulation in situ. Conclusions:Thus, we report here that MDMA given prior to OVA challenge in OVA-sensitized allergic mice is able to decrease lung inflammation and airway reactivity and that hypothalamus-pituitary-adrenal axis activation is partially involved. Together, the data strongly suggest an involvement of a neuroinnmune mechanism in the effects of MDMA on lung inflammatory response and cell recruitment to the lungs of allergic animals. Copyright (C) 2012 S. Karger AG, Basel

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)

FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [09/51886-3]

CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [300764/2010-3]

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)

Identificador

NEUROIMMUNOMODULATION, BASEL, v. 19, n. 4, pp. 209-219, MAY, 2012

1021-7401

http://www.producao.usp.br/handle/BDPI/41570

10.1159/000334098

http://dx.doi.org/10.1159/000334098

Idioma(s)

eng

Publicador

KARGER

BASEL

Relação

NEUROIMMUNOMODULATION

Direitos

restrictedAccess

Copyright KARGER

Palavras-Chave #3,4-METHYLENEDIOXYMETHAMPHETAMINE #ECSTASY #ALLERGIC LUNG INFLAMMATION #CORTICOSTERONE #LEUKOCYTE MIGRATION #AIRWAY REACTIVITY #II PYRETHROID CYHALOTHRIN #NECROSIS-FACTOR-ALPHA #MDMA ECSTASY #IMMUNE-SYSTEM #METHYLENEDIOXYMETHAMPHETAMINE MDMA #IMMUNOMODULATING PROPERTIES #MACROPHAGE ACTIVITY #LUNG INFLAMMATION #MAST-CELLS #IN-VIVO #ENDOCRINOLOGY & METABOLISM #IMMUNOLOGY #NEUROSCIENCES
Tipo

article

original article

publishedVersion